Vident Investment Advisory’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-33,486
| Closed | -$58.9K | – | 1325 |
|
|
2023
Q1 | $58.9K | Buy |
33,486
+1,243
| +4% | +$2.19K | ﹤0.01% | 1198 |
|
|
2022
Q4 | $101K | Buy |
32,243
+7,562
| +31% | +$23.7K | ﹤0.01% | 1106 |
|
|
2022
Q3 | $121K | Buy |
24,681
+2,471
| +11% | +$12.1K | ﹤0.01% | 1050 |
|
|
2022
Q2 | $92K | Buy |
22,210
+4,396
| +25% | +$18.2K | ﹤0.01% | 1202 |
|
|
2022
Q1 | $103K | Sell |
17,814
-3,640
| -17% | -$21K | ﹤0.01% | 1229 |
|
|
2021
Q4 | $161K | Buy |
+21,454
| New | +$161K | ﹤0.01% | 1161 |
|
|
2021
Q3 | – | Sell |
-18,172
| Closed | -$218K | – | 1228 |
|
|
2021
Q2 | $218K | Buy |
+18,172
| New | +$218K | 0.01% | 1020 |
|